Bethel University

Spark
Honors Student Works

College of Arts and Sciences

Spring 2011

Constructing a Vector for Over Expressing Nitrobenzene
Dioxygenase in E. coli
Paul Davis
Bethel University

Follow this and additional works at: https://spark.bethel.edu/honors-works
Part of the Molecular Biology Commons

Recommended Citation
Davis, Paul, "Constructing a Vector for Over Expressing Nitrobenzene Dioxygenase in E. coli" (2011).
Honors Student Works. 4.
https://spark.bethel.edu/honors-works/4

This Honors Paper is brought to you for free and open access by the College of Arts and Sciences at Spark. It has
been accepted for inclusion in Honors Student Works by an authorized administrator of Spark. For more
information, please contact kent-gerber@bethel.edu.

Constructing a Vector for Over Expressing
Nitrobenzene Dioxygenase in E. coli
Paul Davis
5-13-11
Abstract:
Due to extensive use of nitroaromatic compounds in the production of dyes,

pesticides, explosives, and their harmful effects on the environment, studying the
enzyme mechanisms of bacteria capable of utilizing these compounds as nutrient

sources have become a recent field of development. One example, the Comamonas

sp. strain JS765, grows on nitrobenzene as its sole carbon, nitrogen and energy

source. This bacterium contains a nitrobenzene dioxygenase enzyme system that
incorporates O2 into the nitrobenzene ring to form catechol and nitrite. In this
project, the genes that code for the dioxygenase enzyme were cloned and then

transformed into an expression vector for over-expression in E. coli NEB 5α and E.
coli BL21 (DE3). This over-expression system will facilitate purification of the
normal enzyme and of mutant forms for mechanistic studies.
Introduction:
Nitroaromatic compounds are commonly used as industrial feedstocks for the
production of pesticides, dyes, and explosives.1 When these compounds enter the
environment through improper storage and disposal techniques, they present a hazard to
living organisms. One solution for properly digesting these compounds before or after
they have been introduced to the environment has been the use of aerobic bacteria that
are capable of degrading these compounds. Due to the resistance of aromatic compounds,

such as nitrobenzene, the digestion of these compounds through the use of bacteria has
been found to be specific to each bacterium rather than any one bacterium being able to
digest a range of aromatic compounds. One such bacterium that is capable of digesting a
nitroaromatic ring is the Comamonas sp. strain JS765. This bacterium digests
nitrobenzene through a multicomponent dioxygense1, and it is the physical mechanism of
this molecular degradation that is of interest in this study.
The enzyme responsible for this degradation is nitrobenzene dioxygenase
(NBDO), which is in the Rieske nonheme iron dioxygenase family. Rieske dioxygenases
are a target of significant research for two main reasons; first, they incorporate two chiral
centers adjacent to one another without producing stereochemical mixtures, and secondly
they catalyze the first reaction in a pathway by which microbes break down aromatic
compounds so that they can re-enter the global carbon cycle.2 The reaction by which
NBDO breaks down nitrobenzene can be seen in Figure 1, which shows that NBDO

Figure 1: Enzymatic reaction of NBDO, depicting the characteristic cis-dihydroxilation
reaction of a Rieske dioxygenase.3

utilizes an O2 molecule from the atmosphere to oxidize the aromatic ring in a manner
such that they are incorporated onto the same side of the ring. Also, an important
environmental feature of this reaction is that it is converting nitrobenzene, an
environmentally hazardous chemical, to catechol, which is activated by virtue of having

two adjacent hydroxyl groups on the ring. The benzene ring of catechol is then
oxidatively cleaved by catechol dioxygenases, and the products are subsequently
degraded to common metabolites, such as intermediates of the citric acid cycle.2
When looking at the gene sequence that codes for the overall nitrobenzene
dioxygenase system (NBDOS), it is composed of five particular sequences; nbzAa, Orf2,
nbzAb, nbzAc, and nbzAd1. However, NBDOS is only composed of three proteins;
NBDR (for reductase), NBDF (ferredoxin), NBDO (for oxygenase). The nbzAa gene
codes for NBDR, an iron- sulfur flavoprotein reductase (NBDR), and the nbzAb codes
for ferredoxinNBZ, a Reiske ferredoxin (NBDF). While both of these proteins are
necessary for the NBDOS to function in vivo, it was the nbzAc and nbzAd genes that
were of interest to this study. They code for oxygenaseNBZα, and oxygenaseNBZβ
respectively, which are the α and β subunits of the NBDO enzyme.
While it is unknown exactly how the NBDOS catalyzes the conversion of
nitrobenzene to the corresponding cis-diol, a basic understanding has been established
from other studies of Rieske dioxygenases. Two electrons are passed from the iron-sulfur
flavoprotein reductase, which acts as an electron redox switch, to the Rieske ferredoxin
which contains a iron-cluster capable of being reduced by the electrons.4 These electrons
are then passed to NBDO, where O2 binds to the mononuclear iron center and becomes
reduced to a (hydro)peroxo intermediate once nitrobenzene is introduced to the reaction.
Two hypotheses have been put forward to describe how the oxygen-oxygen bond is
cleaved so that the oxygen atoms can be inserted into nitrobenzene, as seen in Figure 2.
One proposal is that the reaction proceeds through a concerted process where the

(hydro)peroxo intermediate reacts directly with nitro benzene5, while the other is a two
step process that forms a very reactive Fe(V) intermediate.6,7
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Figure 2: Proposed reaction mechanisms for cis-dihydroxylation of nitrobenzene.3

In order to determine which of the two proposed pathways is correct, it is
necessary observe the intermediates that are being formed during the reaction. There is
one report5 of the detection of a peroxo-iron(III) intermediate by Mössbauer spectroscopy
when a related Rieske dioxygenase was reacted with hydrogen peroxide and its substrate,
but thus far neither this species nor the Fe(V) intermediate has not been detected during
the reaction with O2 and aromatic substrate. We hope to improve the likelihood of
observing a reactive intermediate through the use of mutant enzymes and/or alternate
substrates designed to maintain the normal rate of formation but slow the rate at which
the intermediate decays. One way in which this might be done would be to mutate the
asparagine 258 residue of the oxygenase subunit.8 In a study by Parales et. al, a series of
mutations were discussed, and it is the mutation from asparagine to valine at residue 258

that is of particular interest given our goal.8 The group used a starting reactant of 4nitrotoluene and monitored the product that was made. In this case, the untreated protein
produced 4-methylcatechol 95% of the time, as opposed to the mutant which produced 4nitrobenzylalcohol 99% of the time (Figure 3).8 This difference in product distribution
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Figure3: Different products based on the 258 residue.8

indicates that the asparagine in the 258 position must have a significant role in the
orientation of the incoming reactant, probably by way of hydrogen bonding to the nitro
group of the substrate, because valine is incapable of such bonding (orientation of
nitrobenzene in active site is displayed in Figure 4). It seems likely that the steps of the
mechanism that generate the activated oxygen species in this mutant, such as the binding

of substrates and the reduction of O2, would remain unchanged relative to the native
enzyme. However, because the substrate is presented to the intermediate in a different
orientation, it seems likely that the rate of reaction of the substrate with the activated
oxygen intermediate will be affected, facilitating the observation of this intermediate
through spectroscopic techniques.

N258
3.06 Å

Nitrobenzene
4.9 Å

4.4 Å

Figure 4: Orientation of nitrobenzene in the active site of NBDO.4

The goal of this project is to accomplish the initial preparations for carrying out
large-scale productions of native or mutant proteins by cloning the nbzAc, and nbzAd
genes into an expression vector and transforming them into E. coli (New England
Biolabs, Inc. Cat. No. C2987I) NEB 5α and E. coli BL21 (DE3) for the over production
of the α and β NBDO dioxygenase subunits. E. coli was selected because it is readily

available, inexpensive, easier to grow in the laboratory than Comamonas sp. strain JS765,
commonly used for molecular biology applications, and does not express its own native
NBDO system.

Materials and Methods:
The Comamonas sp. strain JS765 used was grown in either Difco Nutrient agar
and Difco Nutrient broth, or BLK agar and BLK broth. However, the conditions used for
the BLK agar and broths were determined by the concentration of the nitrogen and
carbon source nitrobenzene. BLK is a minimal media that lacks a carbon and nitrogen
source,16 and in this study succinate was added to this media as the primary carbon source
and nitrobenzene was used as the sole nitrogen source and secondary carbon source. The
conditions used for bacterial growth was a nitrobenzene concentration of 0.750 mM for
the broths, and the placement of a pipette tip filled with 0.750 mM nitrobenzene solution
on the cap of a BLK agar plate. Comamonas was incubated at 30° C, and the liquid
cultures were shaken at 250 rpm.
The genomic DNA was obtained by using the Gram-positive bacteria purification
protocol from the DNeasy® Blood & Tissue Isolation Kit (Qiagen) because Comamonas
sp. Strain JS765 is classified as a gram-positive bacterium in fresh cultures. The kit
included a lysis buffer and proteinase K for cell lysis and protein degradation
respectively, and it utilized a DNeasy Mini spin column and collection tubes for washing
and collecting the desired DNA. Each sample was collected by eluting the DNA with
buffer twice into the same collection tube to ensure maximal yield. Elution of the sample
was then verified by gel electrophoresis using a 1% agarose gel with ethidium bromide as

the staining agent. Gels were visualized using a UV broad-spectrum light and DNA
concentrations were determined by UV-spectroscopy prior to loading the gels.
Following genomic isolation, the Polymerase Chain Reaction (PCR) was used to
amplify the desired α and β subunits of the NBDOS. PCR reactions contained1.1 µL of
both forward and reverse primers (10 µM stock), 100 µg of sample DNA, 45 µL of
Platinum PCR Supermix, and sufficient sterile deionzied water so that the total reaction
volume was 55 µL. Forward and reverse primers for amplifying the nbzAc and nbzAd
genes were designed according to the following criteria: each primer contains
approximately 20 nt that are complimentary to the desired sections of the NDBO genes,
their overall length was minimal to reduce the chances of binding to themselves but
sufficient to be specific to only our area of interest, and that their Tm values were within
5°C of each other. As for the actual primers designed, the forward primer was a 38 bp
long strand including the Sgf I restriction site with a total melt temperature of 64°C and a
melt temperature of 53°C for the homologous region, and the reverse primer was a 33 bp
long strand including the Pme I restriction site with a total melt temperature of 63°C and
a melt temperature of 54°C for the homologous region. For the specific primer sequence
see Table 3. The reaction conditions were then set to a hot start of 3.5 minutes at 94°C, 5

Table 3: Information on the forward and reverse primers used for PCR amplification and
engineering of the Sgf I and Pme I restriction sites onto the NBDO genes.
Length (bp) Full Melt
Homologous
Temp
Region Melt Temp
Forward Primer 38
64°C
53°C
Reverse Primer 33
63°C
54°C
Forward Primer
5’- TTA TGC GAT CGC CAT GAG TTA
Sequence
CCA AAA CTT AGT GAG TG – 3’
Reverse Primer 5 CGT AGT TTA AAC CAG GAA GAC CAA
Sequence
CAG GTT GTG 3

Table 4: Color code guide for the primer sequence in Table 3.
Color
Yellow
Green
Dark Blue
Purple
Light Blue
Red

What it is
Start codon of alpha subunit (2528 -30 bp)
SgfI restriction sequence
4 extra bp
Codon before/upstream of stop codon for
the beta subunit (4465-67 bp)
PmeI restriction sequence
4 extra bp

cycles of: 94°C for 30 seconds, 48°C for 30 seconds, and 72°C of 2 minutes, then 25
cycles of 94°C for 30 seconds, 54°C for 30 seconds, and 72°C or 2 minutes, and final
cool period of 72°C for 10 minutes and 4°C until removed from the thermocycler. The
PCR product was then analyzed by gel electrophoresis.
The PCR product was purified using the Promega Flexi® Vector Systems Kit,
and then digested using the same kit. This kit utilized three key features; the rare
restriction sites of Pme I and Sgf I, the lethal barnase gene, and the kanamycin resistance
gene.11 The restriction cite tagging was done by engineering one PCR primer with the
reverse primer with the Pme I sequence and the forward primer with the Sgf I. The
presence of a the lethal barnase gene was essential because not all of the plasmids had
inserted genomic DNA, so this barnase gene was located between the two restriction cites
and if one of these plasmids made it to a growth plate they would naturally die off.
Finally, the kanamycin gene was utilized once the plasmids were inserted into the cells,
because if a cell took up one of the transformed plasmids they were able to survive on
kanamycin laced growth media. The digestion process then required the purified PCR
product and the Promega Flexi® vector to be digested separately using 4 µL of a 5x

Flexi® Digest Buffer, 2 µL of the Flexi® enzyme blend (Sgf I and Pme I) and up to 200
ng of the purified PCR sample and the Promega Flexi® vector. The vector chosen for the
transformations of both E. coli strands was the pF1K T7 Flexi® Vector (seen in Figure
5). This vector was chosen in combination with E. coli (New England Biolabs, Inc. Cat.

Figure 5: The restriction map of the pF1K T7 Flexi® Vector.10
The Sgf 1 is located at100 bp, Pme 1 is located at 499, the T7
promoter is located at 21 bp and the lacO is located at 39.
No. C2987I) NEB 5α because it is a commonly used cell line for subcloning due to its
lack of nucleases commonly found in other strains that would destroy the recombinant
DNA the project is trying to generate, and E. coli BL21 (DE3) was chosen because it is
able to produce the T7 RNA polymerase necessary for transcribing the NBDO gene
located in the plasmid vector for later expression studies. The T7 RNA polymerase is a
viral polymerase responsible for transcribing the inserted α and β NBDO genes, which
will be inserted immediately downstream from a T7 promoter on the vector, and it is not
found naturally in any prokaryotic cell lines.9 What this means is that E. coli BL21

(DE3) is a line of E. coli that was previously genetically engineered to incorporate the
gene responsible for the production of the T7 RNA polymerase. Also, this means that
along with the α and β NBDO genes being present on the vector there must be a T7
promoter and transcription regulatory genes. Gene expression is regulated in the T7
Flexi® Vector by the lac operon. When the lactose analog IPTG is present, the lac
operator is not repressed and transcription of the gene proceeds rapidly due to the abilities
and tendencies of the viral T7 promoter and T7 RNA polymerase.9 Since the maximum
volume of the digest blend was 20 µL and the PCR product was not of high enough
concentration to max out the 500 ng limit of the digest, all samples ran used a full 12 µL
of purified PCR product to maximize the plasmid concentration (12 µL was the
maximum volume aloud for in the reaction after the volumes required for the buffer and
restriction enzymes were added). The digestion required a 30 minute incubation in a
37°C water bath for both samples and a second incubation of the vector in a 65°C water
bath for 20 minutes. The PCR product and digested vector were then purified separately
using a Wizard® SV Minicolumn and multiple rounds of washing by the according to the
standard protocol described in the Promega Flexi® Vector technical manual. Finally, the
purified, digested PCR product was ligated to the purified, digested vector. The ligation
reaction consisted of 10 µL of 2x Flexi® Vector Buffer, 5 µL of digested vector, 4 µL of
digested PCR product, and 1 µL of T4 DNA ligase followed by a hour long incubation at
room temperature.
Competent E. coli (New England Biolabs, Inc. Cat. No. C2987I) NEB 5α cells
were transformed with the products of the ligation reaction according to the High
Efficiency Transformation protocol from New England Biolabs (protocol CC2987). In

this transformation procedure, 50 µL of cells were mixed with 5 µL (up to 100µg) of the
ligated plasmid. The mixture was incubated for 30 minutes in an ice-water bath, 30
seconds at 42°C and then again on ice for 5 minutes. 950 µL of LB broth was then added
and the mixture was incubated at 37°C for 1 hour in a shaker at 250 rpm. Cells were then
plated onto Difco Nutrient agar plates containing the antibiotic kanamycin (50 µg/mL) to
inhibit the growth of any E. coli cells that were not successfully transformed with the
plasmid.
Plasmids from kanamycin-resistant transformants were isolated using the
Quantum Prep Plasmid Mini Prep Kit (BioRad). Cells were grown in LB broth
containing kanamycin (50 µg/mL) and harvested by centrifugation at 14,000xg. The
cells were resuspended in the Cell Resuspension solution, then lysed using a lysis
solution, and a Neutralization Solution to denature any proteins and stabilize the plasmid.
The sample was then washed with buffer and collected by centrifugation and loaded onto
a Wizard® SV Minicolumn. The sample bound to the column was washed with wash
buffer and then eluted out in H2O. The identification of proper transformation and
isolation was then verified by gel electrophoresis of the product.
Following the isolation of the plasmid, the plasmid was transformed into E. coli
BL21 (DE3). The transformation reaction contained 50 µL of cells and 100 ng of
plasmid DNA. Incubations of 30 minutes on ice, a 10 second heat shock at 42°C, and
then 5 minutes on ice again. 950 µL of SOC was then added and the solution was mixed
at 37°C for 1 hour in a shaker at 250 rpm. After this incubation, the cells were plated out
onto LB plates containing kanamycin and incubated overnight at 37°C.

Results:
The Comamonas sp. strain JS765 bacteria was found to grow best in a solution of
BLK with a concentration of nitrobenzene at 0.750 mM. A series of tests were done in
effort to find the most effective growing conditions, and the results of these tests can be
seen in the Table 1.
Table 1: Nitrobenzene concentration dependence of Comamonas
growth measured by UV-vis spectroscopy.
Nitrobenzene (mM) Abs (600 nm)
0

0.26

0.250

0.44

0.500

0.67

0.750

0.80

1.000

0.67

1.250

0.59

1.500

0.21

The integrity of the genomic DNA isolated from Comamonas sp. strain JS765
using the Qiagen DNeasy® Blood and Tissue Isolation Kit was verified by agarose gel
electrophoresis. The concentration of the genomic DNA was measured by UV-visible
spectrometry. The spectrophotometric results showed a range on concentrations from
16.59 ng/µL to 45 ng/µL, and the results can be seen in Table 2. The band located in
Table 2: Absorbencies of collected genomic DNA of Comanomas sp.
Strain JS765 as measured by UV spectroscopy.
Abs (260 nm)

Abs (280 nm)

ng/µL

0.3318

0.1652

16.59

0.4441

0.2122

22.21

0.6050

0.3125

30.25

0.3994

0.1732

19.97

0.90

0.55

45.

0.48

0.24

24.

Lane 4 of the gel indicates the genomic DNA due to its incredibly large size estimated at
approximately 5 Mbp and can be see on Figure 6.

Figure 6: Gel of genomic DNA following the DNeasy Blood &
Tissue Kit

After the genome was isolated, PCR was carried out under the conditions
defined in the Materials and Methods section. The products of the PCR were analyzed by
gel electrophoresis. The expected size of the PCR amplified product was a 1965 bp
strand. However, as seen in Figure 7, the resulting strand was 2320 bp. This difference

Figure 7: Gel of the amplified PCR product.

in size was deemed to be an acceptable deviation from the expected size, and the project
was continued using these strands.
Following the PCR amplification, the product was digested using Sgf I and Pme
I and ligated to the pF1K T7 Flexi Vector as described in the Materials and Methods
section. This ligated product was then analyzed by gel electrophoresis, as seen by Figure
8. The expected size of the ligated plasmid was a circular plasmid of 5069 bp, which is
the sum of the 1965 bp PCR product and the 3104 bp digested vector. Figure 8 shows
that, when the plasmid construct was digested with Eco RI, a single band was observed at
6699 bp. And as seen in Figure 8, there is no such band at 5069 bp. However, the gel

Figure 8: Gel of the ligated vector/NBDO gene plasmid. Lanes 1 and
4 are uncut plasmids, while lanes 3 and 5 are samples of the plasmid
cut with EcoR1 and are thus linear.

does suggest successful ligation because lanes 1 and Lane 4 contains the undigested
circular ligated plasmid. Since the multiple bands seen in lane 4 all collapsed into one
band in Lanes 3, it appeared as though the desired plasmid construct had been produced.
As with the PCR results, even though the resulting product was larger than expected, the
study proceeded to the next step, namely transformation of E. coli NEB 5α. This
decision was made because the product would be sequenced later on in the study, and this
later sequencing data is ultimately what is needed for confirming or rejecting that the
gene was successfully cloned.
The transformation of the E. coli NEB 5α with the plasmid DNA construct
generated kanamycin-resistant clones. Kanamycin resistance is conferred by the Flexi

Vector. In addition, since transformants carrying the original pF1K T7 Flexi Vector are
not viable due to the lethal barnase gene, presumably all of the transformants carry
foreign DNA. Figure 9 shows a negative control, in which untransformed NEB-5α cells
were plated on nutrient agar plates containing kanamycin. As seen there is no growth
evident on the plate indicating that the kanamycin successfully kills all bacteria that do
not contain the kanamycin gene, such as the one found in the vector. In contrast, Figure
10 shows the results of the transformation experiment. Colonies indicate successful
transformation because it must contain the kanamycin resistance gene found in the
inserted plasmid. Also, it suggests that the plasmid contains the NBDO genes because
the barnase gene, which would kill the bacteria, is absent from the inserted plasmid
because the cells were able to grow and form colonies.

Figure 9: Picture of the negative control.

Figure 10: Picture of the transformed E. coli NEB 5α cells.
Sequencing was performed on the plasmids collected from three colonies of the
transformed E. coli NEB 5α cells (Northwoods DNA Inc, Bemidji, MN). The resulting
sequencing indicated that the NBDO gene was contained within the plasmid of more than
one of the clones. Two of the clones showed improper copying of additional sequences,
however, one clone showed proper sequencing except for a single amino acid, which is
not found in or near the active site. So from these sequencing results, it was concluded
that the NBDO was properly ligated into the vector, and that it was done so with the
proper sequence.
After verifying that the ligated sequence was correct, the plasmid was isolated
from the E. coli NEB 5α cell line and transformed into the E. coli BL21 (DE3) cell line.
Again, Difco nutrient agar was used with kanamycin added. And as seen in Figure 11,
transformants were successfully grown.

Figure 11: Picture of the transformed E. coli BL 21 (DE3) cells.

Conclusion
The overarching goal of this study is to determine the reaction mechanism of
the Rieske dioxygenase enzyme found in the bacteria Comamonas sp. strain JS 765, and
while this was not determined in this specific project, the first step necessary for this goal
was successfully performed. As seen by the sequencing results and the successful growth
of both the transformed E. coli (New England Biolabs, Inc. Cat. No. C2987I) NEB 5α
and the E. coli BL21 (DE3) cell lines on kanamycin containing Difco Nutrient agar
plates, it can said that the desired α and β subunits of the NBDOS were successfully
cloned and are suitable for further use in the amplification and over production of the
desired native Rieske enzyme and of the mutated Rieske enzyme. It is important to note
that while the gene was cloned into these cell lines, it may be necessary to use a
mutagenesis kit to change the cell line containing the single-nucleotide polymorphism

(SNP) back to the original nucleotide because this SNP changed the nucleotide from an
adenosine to a guanine. Ultimately, it was not determined in this project if the change in
amino acid substantially effected the function of the enzyme even though it was
determined to be located away from the active site of the enzyme, but because the
sequencing error was only a single change in nucleotide the cloning was determined to be
a success and moving on towards mutating the enzyme for further study is going to be the
next step for the project as a whole.
What this next step in the project would include after the mutation would be
growing both the native protein and the mutated protein and comparing the rate at which
O2 is removed from the environment. This rate of O2 loss would indicate the rate at
which the enzyme was working because the enzyme uses atmospheric O2 for the oxygen
involved in the cis-dihydroxylation. And if it is found that the mutant is cable of utilizing
the atmospheric O2 and its enzymatic rate is slower than that of the native protein, then it
may be possible to capture any intermediate reactants, possibly the postulated Fe(V)
intermediate.
So while this study was unable to reach the point of studying the actual
enzymatic mechanisms of the enzyme at hand, it was able to accomplish the first step of
the process by successfully cloning the NBDO genes into both the E. coli (New England
Biolabs, Inc. Cat. No. C2987I) NEB 5α and the E. coli BL21 (DE3) cell lines. Cloning
the genes into these two cell lines accomplished two major advantages. The first being it
is much easier to grow mass quantities of E. coli than Comamonas. The second being the
E. coli BL21 (DE3) cell line is a line of E. coli designed for expressing proteins in higher
than normal amounts, so when it is necessary for over-expressing the enzyme of interest

it will be possible to produce more protein per cell than if it were to be left in the initial
Comamonas cell line.
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